Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis

被引:15
|
作者
Wu, Ben J. [1 ,2 ,3 ]
Shrestha, Sudichhya [1 ,2 ]
Ong, Kwok L. [1 ,2 ,3 ]
Johns, Douglas [4 ]
Dunn, Louise L. [2 ,5 ]
Hou, Liming [1 ,2 ]
Barter, Philip J. [1 ,2 ,3 ]
Rye, Kerry-Anne [1 ,2 ,3 ]
机构
[1] Univ New S Wales, Lowy Ctr, Ctr Vasc Res, Sydney, NSW 2052, Australia
[2] Heart Res Inst, Sydney, NSW 2042, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[4] Merck & Co Inc, Kenilworth, NJ 07033 USA
[5] Victor Chang Cardiac Res Inst, Vasc Biol Div, Sydney, NSW 2010, Australia
基金
英国医学研究理事会;
关键词
Angiogenesis; High density lipoproteins; Ischemia; Lipoproteins; CETP inhibition; HIGH-DENSITY-LIPOPROTEINS; ENDOTHELIAL PROGENITOR CELLS; REPERFUSION INJURY; HIGH-RISK; RECEPTOR; REPAIR; HEART;
D O I
10.1016/j.ijcard.2015.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: High density lipoprotein (HDL) infusions increase new blood vessel formation (angiogenesis) in rodents with ischemic injury. This study asks if increasing HDL levels by inhibiting cholesteryl ester transfer protein (CETP) activity increases angiogenesis in New Zealand White (NZW) rabbits with hindlimb ischemia. Methods and results: NZW rabbits were maintained for 6 weeks on chow or chow supplemented with 0.07% or 0.14% (wt/wt) of the CETP inhibitor, des-fluoro-anacetrapib. The left femoral artery was ligated after 2 weeks of des-fluoro-anacetrapib treatment. The animals were sacrificed 4 weeks after femoral artery ligation. Treatment with 0.07% and 0.14% (wt/wt) des-fluoro-anacetrapib reduced CETP activity by 63 +/- 12% and 81 +/- 8.6%, increased plasma apoA-I levels by 1.3 +/- 0.1-and 1.4 +/- 0.1-fold, and increased plasma HDL-cholesterol levels by 1.4 +/- 0.1- and 1.7 +/- 0.2-fold, respectively. Treatment with 0.07% and 0.14% (wt/wt) des-fluoro-anacetrapib increased the number of collateral arteries by 60 +/- 16% and 84 +/- 27%, and arteriole wall area in the ischemic hindlimbs by 84 +/- 16% and 94 +/- 13%, respectively. Capillary density in the ischemic hindlimb adductor muscle increased from 1.1 +/- 0.2 (control) to 2.1 +/- 0.3 and 2.2 +/- 0.4 in the 0.07% and 0.14% (wt/wt) des-fluoro-anacetrapib-treated animals, respectively. Incubation of HDLs from des-fluoro-anacetrapib-treated animals with human coronary artery endothelial cells at apoA-I concentrations comparable with their plasma levels increased tubule network formation. These effects were abolished by knockdown of scavenger receptor-B1 (SR-B1) and PDZK1, and pharmacological inhibition of PI3K/Akt. Conclusion: Increasing HDL levels by inhibiting CETP activity is associated with increased collateral blood vessel formation in NZW rabbits with hindlimb ischemia in an SR-B1- and PI3K/Akt-dependent manner. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:204 / 212
页数:9
相关论文
共 14 条
  • [1] Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
    Cao, Guoqing
    Beyer, Thomas P.
    Zhang, Youyan
    Schmidt, Robert J.
    Chen, Yan Q.
    Cockerham, Sandra L.
    Zimmerman, Karen M.
    Karathanasis, Sotirios K.
    Cannady, Ellen A.
    Fields, Todd
    Mantlo, Nathan B.
    JOURNAL OF LIPID RESEARCH, 2011, 52 (12) : 2169 - 2176
  • [2] RELATION OF POLYMORPHISMS IN THE CHOLESTERYL ESTER TRANSFER PROTEIN GENE TO TRANSFER PROTEIN-ACTIVITY AND PLASMA-LIPOPROTEIN LEVELS IN ALCOHOL DRINKERS
    HANNUKSELA, ML
    LIINAMAA, MJ
    KESANIEMI, YA
    SAVOLAINEN, MJ
    ATHEROSCLEROSIS, 1994, 110 (01) : 35 - 44
  • [3] Increased cholesteryl ester transfer protein activity in impaired glucose tolerance: Relationship to high density lipoprotein metabolism
    Pietzsch, J
    Fuecker, K
    CROATIAN MEDICAL JOURNAL, 2003, 44 (02) : 171 - 177
  • [4] The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity
    Park, Ki-Hoon
    Shin, Dong-Gu
    Kim, Jae-Ryong
    Hong, Joo-Heon
    Cho, Kyung-Hyun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (01) : 129 - 136
  • [5] Lowering of serum cholesteryl ester transfer protein -: But not lecithin:cholesterol acyltransferase -: Activity levels by hypocholesterolemic drugs in the rabbit
    Meijer, GW
    Groener, JEM
    Beynen, AC
    Van Tol, A
    CARDIOVASCULAR DRUGS AND THERAPY, 1998, 12 (01) : 13 - 18
  • [6] Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency -: Veterans Affairs HDL Cholesterol Intervention Trial
    Brousseau, ME
    O'Connor, JJ
    Ordovas, JM
    Collins, D
    Otvos, JD
    Massov, T
    McNamara, JR
    Rubins, HB
    Robins, SJ
    Schaefer, EJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) : 1148 - 1154
  • [7] INCREASED HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL CONCENTRATION IN ALCOHOLICS IS RELATED TO LOW CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY
    SAVOLAINEN, MJ
    HANNUKSELA, M
    SEPPANEN, S
    KERVINEN, K
    KESANIEMI, YA
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (06) : 593 - 599
  • [8] Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease
    Furtado, Jeremy D.
    Ruotolo, Giacomo
    Nicholls, Stephen J.
    Dullea, Robert
    Carvajal-Gonzalez, Santos
    Sacks, Frank M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2022, 42 (02) : 227 - 237
  • [9] Tag single nucleotide polymorphism rs1532624 located in cholesteryl ester transfer protein gene is associated with atherosclerosis cerebral ischemia
    Huang, Lin
    Wang, Dan-Xin
    Zhou, Li-Min
    Wang, Tao
    Zhang, Hai-Ying
    Zhang, Yun-Xia
    Zhang, Yin-Dong
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2018, 11 (04) : 309 - 312
  • [10] HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes
    Coniglio, R. I.
    Merono, T.
    Montiel, H.
    Malaspina, M. M.
    Salgueiro, A. M.
    Otero, J. C.
    Ferraris, R.
    Schreier, L.
    Brites, F.
    Rosso, L. Gomez
    CLINICAL BIOCHEMISTRY, 2012, 45 (7-8) : 566 - 570